Oral Vaccination Based on DNA-Chitosan Nanoparticles againstSchistosoma mansoniInfection

DNA vaccines: A safe and efficient platform technology for responding to emerging infectious diseases

(2014) Julie E. Ledgerwood et al.   Human vaccines & immunotherapeutics

The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells

(2011) Liang Chen et al.   NANOTECHNOLOGY

Controlling and Coordinating Development in Vector-Transmitted Parasites

(2011) K. R. Matthews   SCIENCE

Elimination of Neglected Diseases in Latin America and the Caribbean: A Mapping of Selected Diseases

(2011) Maria Cristina Schneider et al.   PLoS Neglected Tropical Diseases

Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone

(2009) C. Moreira et al.   Acta Biomaterialia

Chitosan-based systems for the delivery of vaccine antigens

(2009) H. Çiğdem Arca et al.   Expert Review of Vaccines

Toward the Elimination of Schistosomiasis

(2009) Charles H. King   NEW ENGLAND JOURNAL OF MEDICINE

Recent advances in vaccine research against schistosomiasis in Brazil

(2008) Sergio C. Oliveira et al.   ACTA TROPICA

Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni

(2007) Heloisa H. Marques et al.   IMMUNOBIOLOGY